Latest | F'cast | |
---|---|---|
Div Yield | 2.6% | 0.0% |
Div Cover | 3.7 | 2.6 |
Op Mrgn | 22.2% | 27.2% |
ROCE | 67.1% |
Latest | F'cast | |
---|---|---|
P/E | 10.5 | 10.2 |
PEG | 1.0 | 9.8 |
Pr/Revenue | 2.2 | 2.1 |
Pr/Book | 5.3 |
Latest | F'cast | |
---|---|---|
Revenue | 3.4% | 5.1% |
PBT | 7.7% | 43.1% |
EPS | 11.0% | 0.1% |
DPS | -4.5% | 44.7% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 33,754.00 | 6,221.00 | 123.90p | 17.9 | 4.5 | +4% | 80.00p | 3.6% |
31-Dec-20 | 34,099.00 | 6,968.00 | 115.90p | 14.5 | n/a | -6% | 80.00p | 4.8% |
31-Dec-21 | 24,696.00 | 3,599.00 | 90.56p | 22.2 | n/a | -22% | 80.00p | 4.0% |
31-Dec-22 | 29,324.00 | 5,628.00 | 139.70p | 10.3 | 0.2 | +54% | 44.00p | 3.1% |
31-Dec-23 | 30,328.00 | 6,064.00 | 155.10p | 9.4 | 0.9 | +11% | 42.00p | 2.9% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 31,875.77 | 8,675.36 | 155.21p | 10.5 | 143.9 | 0% | 60.76p | 0.0% |
31-Dec-25 | 33,446.37 | 9,646.65 | 175.24p | 9.3 | 0.7 | +13% | 64.78p | 0.0% |
31-Dec-26 | 35,112.27 | 10,666.03 | 192.73p | 8.5 | 0.9 | +10% | 69.18p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
US FDA accepts new indication filing for Jemperli | 24-Apr-2024 | 07:00 | RNS |
Director/PDMR Shareholding | 19-Apr-2024 | 15:30 | RNS |
Director/PDMR Shareholding | 17-Apr-2024 | 15:30 | RNS |
GlaxoSmithKline scraps sale of old drugs | 05-Dec-2014 | Telegraph |
Glaxo sharpens axe to save £1bn as insurers and ... | 01-Dec-2014 | The Independent |
GSK to cut hundreds of US jobs | 01-Dec-2014 | Telegraph |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
16-Apr-24 | Buy Dividends | Hal Barron | 3,202.70p | 2,906,213 | £93,077,316.08 |
16-Apr-24 | Buy Dividends | Emma Walmsley | 1,611.28p | 1,840,922 | £29,662,409.10 |
12-Apr-24 | Buy Dividends | Vishal Sikka | 3,289.66p | 43 | £1,414.56 |
Currency | UK Pounds |
Share Price | 1,636.00p |
Change Today | -15.00p |
% Change | -0.91 % |
52 Week High | 1,711.20 |
52 Week Low | 1,316.00 |
Volume | 3,447,340 |
Shares Issued | 4,144.88m |
Market Cap | £67,810m |
RiskGrade | 129 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 8 |
Buy | 5 |
Neutral | 9 |
Sell | 2 |
Strong Sell | 0 |
Total | 24 |
Latest | Previous | |
---|---|---|
Q4 | Q3 | |
Ex-Div | 22-Feb-24 | 16-Nov-23 |
Paid | 11-Apr-24 | 11-Jan-24 |
Amount | 16.00p | 14.00p |
Time | Volume / Share Price |
16:35 | 1,685,159 @ 1,636.00p |
16:35 | 3,275 @ 1,636.00p |
16:35 | 7,889 @ 1,636.00p |
16:35 | 814 @ 1,636.00p |
16:35 | 385 @ 1,636.00p |
You are here: research